Gnosis by Lesaffre Joins ILSI Europe’s New Vitamin K2 Task Force

Gnosis by Lesaffre Joins ILSI Europe’s New Vitamin K2 Task Force

  • News• Vitamin K2

Share this article:

Gnosis by Lesaffre Joins ILSI Europe’s New Vitamin K2 Task Force

With ever-growing evidence of the importance of Vitamin K2, not only for stronger bone and heart health but also for other critical functions in the body, raising public awareness is crucial. As Gnosis by Lesaffre joins ILSI’s newly established Task Force on Vitamin K2, we are taking a joint step further. 

ILSI Europe (International Life Sciences Institute) fosters collaboration among leading scientists to provide evidence-based scientific consensus on nutrition, food safety, toxicology, risk assessment, and the environment. In February 2024, it launched a new task force on Vitamin K2 to advance health understanding and economic insights. 

Building on A Foundation of Clinical Research

ILSI’s newly formed task force signifies the solid scientific foundation of Vitamin K2 as MK-7. MenaQ7®, known as the most clinically proven vitamin K2 as MK-7 in the market, has demonstrated support for strong bone health in both children and adult populations, as well as supporting robust cardiovascular health. Despite the significance of K2, awareness and understanding among the public remain relatively low. The ILSI Task Force represents a crucial step in bridging the gap between scientific awareness and public understanding.

Increasing K2 Awareness - A Potential for Health Cost Savings

The Task Force’s main objective is to assess the scientific evidence that supports various health benefits linked to Vitamin K2. It aims to identify and evaluate potential biomarkers for monitoring Vitamin K2 status. Further, it will conduct a comprehensive nutrition economic study to determine the potential healthcare cost savings for Europe associated with Vitamin K2 supplementation.

A Panel of Vitamin K2 Experts

Gnosis by Lesaffre has been a pioneering force in shaping the Vitamin K2 industry, and brings MenaQ7®, the most clinically proven K2 as MK-7 for bone and heart health to the market. Our commitment to clinical validation, rigorous scientific standards, and the development of innovative, efficacious products aligns seamlessly with the values of ILSI Europe, making us a natural and integral member of this new Task Force on Vitamin K2.

We are excited to expand our dedication to educating and raising awareness about the health benefits of vitamin K2, now through our involvement in the ILSI Task Force on K2.

Learn more here

Latest news & videos

More news
More news about Wellness & Immune Health

Subscribe to our Youtube channel

High standard of Quality Since 1882

High standard of Quality Since 1882 

Scientific Expertise

Scientific Expertise 

Fermentation Processes

Fermentation Processes

Customer support & Partnerships

Customer support & Partnerships

Lesaffre Logo

Part of Lesaffre

Gnosis by Lesaffre logo
Facebook Twitter Youtube Linkedin

CORPORATE HEADQUARTER
101 rue de Menin
59700 Marcq-en-Baroeul
France

Careers

Lesaffre Activities

Legal Notices

Cookie Policy

Contact Form Policy

Privacy Policy

Quatrefolic®

MenaQ7®

Red Star® Nutritional Yeast

Subscribe to our newsletter

The latest news, articles, and resources, sent to your inbox twice a month. 

The information provided here is, to the best of our knowledge, true and accurate. However, our products must only be used in compliance with local laws and regulations. We cannot guarantee the freedom of use for every intended application or country. These statements may not have been evaluated by your local Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease. A healthy, balanced and diversified diet should fulfill all nutritional needs. 

 

© Gnosis by Lesaffre • We are a proud business unit of Lesaffre.